Concepedia

Ioana Davies

ID

Statistics

Publications

6

Citations

507

H-Index

6

Active since

1997

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Vertex Pharmaceuticals (Canada)

Ioana Davies is an author at Vertex Pharmaceuticals (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

1997–2021

6

Publications

6

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 211 citations · Full text

, , +17

A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care

Laurence Mynors‐Wallis, Ioana Davies, Alastair Gray et al. · The British Journal of Psychiatry · 1997 · 173 citations

, , +13

Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza

Upul K. Bandarage, Michael P. Clark, Emanuele Perola et al. · ACS Medicinal Chemistry Letters · 2017 · 52 citations · Full text

, , +16

Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors

Michael J. Boyd, Upul K. Bandarage, Hamilton B. Bennett et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 33 citations · Full text

, , +14

Development of a Scalable Synthesis of an Azaindolyl-Pyrimidine Inhibitor of Influenza Virus Replication

Jianglin Liang, John E. Cochran, Warren A. Dorsch et al. · Organic Process Research & Development · 2016 · 20 citations

, , +15

1–5 of 6